Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models

SIMPLE SUMMARY: Cancer-associated glycosylation changes are widely used as biomarkers and strongly impact malignancy. However, the clinical significance of the deranged expression of glycosyltransferases observed in specimens is not always consistent with their role in experimental systems. We analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Pucci, Michela, Duca, Martina, Malagolini, Nadia, Dall’Olio, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100214/
https://www.ncbi.nlm.nih.gov/pubmed/35565254
http://dx.doi.org/10.3390/cancers14092128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100214/
https://www.ncbi.nlm.nih.gov/pubmed/35565254
http://dx.doi.org/10.3390/cancers14092128

Ejemplares similares